11b-Hydroxyprogesterone (BioCAD00000231339)
{$topic}
Metabolite Card
Formula: C20H28O4 (332.1987)
SMILES: [H][C@@]12CC[C@H](C(O)=O)[C@@]1(C)C[C@@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Synonyms [en]
11b-hydroxyprogesterone; CID 44263342; (8S,9S,10R,11R,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylic acid; (1S,2R,10S,11S,14S,15S,17R)-17-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-14-carboxylic acid; 11beta-Hydroxypregn-4-ene-3,20-dione; (11beta)-11-Hydroxypregn-4-ene-3,20-dione
Last reviewed on 2024-06-28.
Cite this Page
11b-Hydroxyprogesterone. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000231339). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
11b-Hydroxyprogesterone is a 3-hydroxy steroid. It has a role as an androgen.
DBLinks
- CAS Registry Number:
- PubChem CID: 44263342
- ChEBI: 177269
- HMDB: HMDB0304821
- LipidMaps:
- KEGG:
- BioCyc:
- NCBI MeSH:
- Wikipedia:
Other DBLinks
- PubChem: 44263342
- ChEBI: ChEBI:177269
- HMDB: HMDB0304821
Class / Ontology
- WishartLab ClassyFire: [Androstane steroids] Androstane steroids
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| PathBank:SMP0120690 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0120858 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0120641 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120649 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0000373 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000576 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000718 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0087238 | Steroidogenesis |
| PathBank:SMP0120849 | 17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0120861 | Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0120869 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0120451 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120640 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000575 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000717 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0063672 | Steroidogenesis |
| PathBank:SMP0120672 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120860 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120868 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0120630 | 17-alpha-Hydroxylase Deficiency (CYP17) |